The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
We received an updated WNV package insert; please note the manufacturer and license number has been ...